\-\ Texto\\:\\ \ \(0\)\
\-\ admission\\ findings\\ included\\ dizziness\\,\\ balance\\ disturbances\\,\\ ophthalmoparesis\\ and\\ bilateral\\ sustained\\ clonus\\ with\\ achilles\\ reflex\\.\ \(0\)\
\-\ serial\\ lumbar\\ punctures\\ showed\\ increased\\ wbcs\\.\\ \\ protein\\ and\\ glucose\\ were\\ essentially\\ normal\\.\ \(0\)\
\-\ patient\\ treated\\ with\\ antibiotics\\ initially\\,\\ without\\ significant\\ improvement\\.\\ \\ patient\\ then\\ treated\\ with\\ corticosteroids\\,\\ at\\ which\\ time\\ a\\ significant\\ improvement\\ in\\ symptoms\\ was\\ observed\\.\ \(0\)\
\-\ multifocal\\ enhancing\\ signal\\ abnormalities\\ within\\ brainstem\\ and\\ basal\\ ganglia\\ initially\\,\\ with\\ lesion\\ at\\ grey\\/white\\ matter\\ junction\\ in\\ frontal\\ lobe\\ \\(later\\ finding\\)\\.\\ \\ punctate\\ area\\ of\\ hemorrhage\\ in\\ midbrain\\.\\ \\ subsequent\\ examination\\ revealed\\ new\\ lesions\\.\\ \\ some\\ existing\\ lesions\\ improved\\ over\\ the\\ course\\ of\\ two\\ weeks\\,\\ while\\ others\\ worsened\\.\ \(0\)\
\-\ acute\\ disseminated\\ encephalomyelitis\\ \\(adem\\)\ \(0\)\
\-\ \\â\\€\\¢\\ acute\\ disseminated\\ encephalomyelitis\\ \\(adem\\)\ \(0\)\
\-\ \\â\\€\\¢\\ multiple\\ sclerosis\\ \\(ms\\)\ \(0\)\
\-\ \\â\\€\\¢\\ rhombencephalitis\ \(1\)\
\-\ \\â\\€\\¢\\ lymphoma\ \(6\)\
\-\ 25\\ y\\.o\\.\\ man\\ with\\ a\\ history\\ of\\ presumed\\ viral\\ meningitis\\ one\\ month\\ ago\\.\\ \\ hes\\ has\\ been\\ seen\\ four\\ times\\ at\\ hospital\\ for\\ various\\ focal\\ neurological\\ complaints\\ before\\ these\\ images\\ were\\ obtained\\.\ \(0\)\
\-\ with\\ rapidly\\ progressing\\ neurologic\\ findings\\ following\\ a\\ viral\\ infection\\,\\ the\\ patient\\ in\\ this\\ case\\ demonstrates\\ a\\ typical\\ story\\ for\\ adem\\.\\ \\ on\\ mr\\ imaging\\,\\ the\\ multiple\\ and\\ asymmetric\\ lesions\\ helped\\ to\\ differentiate\\ adem\\ from\\ the\\ fewer\\ and\\ more\\ symmetric\\ lesions\\ of\\ ms\\.\\ \\ additionally\\,\\ the\\ presence\\ of\\ basal\\ ganglia\\ lesions\\ or\\ large\\,\\ globular\\ white\\ matter\\ lesions\\ is\\ more\\ suggestive\\ of\\ adem\\.\\ \\ the\\ uniform\\ enhancement\\ of\\ all\\ the\\ lesions\\ in\\ this\\ patient\\ also\\ suggests\\ a\\ monophasic\\ illness\\,\\ such\\ as\\ adem\\,\\ and\\ the\\ hemorrhagic\\ lesion\\ seen\\ in\\ this\\ patient\\ is\\ not\\ characteristic\\ of\\ ms\\.\\ \\ on\\ initial\\ imaging\\ of\\ this\\ patient\\,\\ only\\ the\\ brainstem\\ lesions\\ were\\ apparent\\,\\ warranting\\ the\\ inclusion\\ of\\ rhombencephalitis\\ in\\ the\\ differential\\.\\ \\ however\\,\\ the\\ appearance\\ of\\ cortical\\ lesions\\ on\\ follow\\-up\\ examination\\ helped\\ to\\ exclude\\ that\\ disease\\ process\\.\\ \\ early\\ and\\ late\\ images\\ in\\ this\\ patient\\ showed\\ a\\ rapidly\\ progressing\\ and\\ remitting\\ pattern\\ unlikely\\ to\\ be\\ produced\\ by\\ a\\ lymphoma\\.\\ \\ additionally\\,\\ this\\ patient\\ demonstrated\\ the\\ tendency\\ for\\ the\\ lesions\\ of\\ adem\\ to\\ worsen\\ radiographically\\ on\\ short\\-term\\ follow\\-up\\,\\ even\\ though\\ the\\ patient\\ improved\\ clinically\\ with\\ treatment\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ adem\\:\\ 0\\.4186382905614665\ \(0\)\
\-\ lesions\\:\\ 0\\.3197884054924527\ \(0\)\
\-\ rhombencephalitis\\:\\ 0\\.17017974109524753\ \(0\)\
\-\ the\\:\\ 0\\.16665883850892604\ \(0\)\
\-\ patient\\:\\ 0\\.1629952187695009\ \(0\)\
\-\ ms\\:\\ 0\\.1622037069067239\ \(0\)\
\-\ helped\\:\\ 0\\.1363157842643053\ \(0\)\
\-\ of\\:\\ 0\\.1307607997439639\ \(0\)\
\-\ encephalomyelitis\\:\\ 0\\.13041446974352386\ \(0\)\
\-\ progressing\\:\\ 0\\.1287866422976477\ \(0\)\
\-\ disseminated\\:\\ 0\\.1206123196427278\ \(0\)\
\-\ this\\:\\ 0\\.11480015804942238\ \(0\)\
\-\ brainstem\\:\\ 0\\.11235704613337676\ \(0\)\
\-\ rapidly\\:\\ 0\\.11137250375409952\ \(0\)\
\-\ in\\:\\ 0\\.11081512174051304\ \(0\)\
\-\ ganglia\\:\\ 0\\.10466700254365725\ \(0\)\
\-\ viral\\:\\ 0\\.10272392409932934\ \(0\)\
\-\ improved\\:\\ 0\\.09882499729306318\ \(0\)\
\-\ improvement\\:\\ 0\\.09721063836773157\ \(0\)\
\-\ basal\\:\\ 0\\.09529367277766297\ \(0\)\
\-\ and\\:\\ 0\\.09204813321454627\ \(0\)\
\-\ additionally\\:\\ 0\\.09171088395687993\ \(0\)\
\-\ ophthalmoparesis\\:\\ 0\\.08904774111237908\ \(0\)\
\-\ hes\\:\\ 0\\.08904774111237908\ \(0\)\
\-\ initially\\:\\ 0\\.08733117085991643\ \(0\)\
\-\ were\\:\\ 0\\.08610748394682176\ \(0\)\
\-\ warranting\\:\\ 0\\.08508987054762376\ \(0\)\
\-\ matter\\:\\ 0\\.08479447150661353\ \(0\)\
\-\ punctures\\:\\ 0\\.0822817166922223\ \(0\)\
\-\ remitting\\:\\ 0\\.0822817166922223\ \(0\)\
\-\ story\\:\\ 0\\.08010354334067986\ \(0\)\
\-\ monophasic\\:\\ 0\\.07681913357384677\ \(0\)\
\-\ with\\:\\ 0\\.07632270875288052\ \(0\)\
\-\ globular\\:\\ 0\\.07436597556271166\ \(0\)\
\-\ showed\\:\\ 0\\.07417638245003438\ \(0\)\
\-\ white\\:\\ 0\\.07347489549688124\ \(0\)\
\-\ fewer\\:\\ 0\\.07333751892052308\ \(0\)\
\-\ tendency\\:\\ 0\\.07155782170731019\ \(0\)\
\-\ examination\\:\\ 0\\.07126242266629997\ \(0\)\
\-\ worsen\\:\\ 0\\.07005310915369\ \(0\)\
\-\ treated\\:\\ 0\\.06934958841044529\ \(0\)\
\-\ clonus\\:\\ 0\\.06815789213215265\ \(0\)\
\-\ wbcs\\:\\ 0\\.06759995114255486\ \(0\)\
\-\ on\\:\\ 0\\.06726775544135787\ \(0\)\
\-\ lymphoma\\:\\ 0\\.06632423297204354\ \(0\)\
\-\ significant\\:\\ 0\\.06429919335965256\ \(0\)\
\-\ disturbances\\:\\ 0\\.06401047561411836\ \(0\)\
\-\ existing\\:\\ 0\\.06401047561411836\ \(0\)\
\-\ at\\:\\ 0\\.06309546058605092\ \(0\)\
\-\ midbrain\\:\\ 0\\.06198364343175195\ \(0\)\
\-\ more\\:\\ 0\\.06115081663554224\ \(0\)\
\-\ inclusion\\:\\ 0\\.06083392672239809\ \(0\)\
\-\ balance\\:\\ 0\\.06056647684502245\ \(0\)\
\-\ corticosteroids\\:\\ 0\\.0603061598213639\ \(0\)\
\-\ acute\\:\\ 0\\.06024373471894263\ \(0\)\
\-\ others\\:\\ 0\\.05865575337085564\ \(0\)\
\-\ differentiate\\:\\ 0\\.05865575337085564\ \(0\)\
\-\ imaging\\:\\ 0\\.05852561726464233\ \(0\)\
\-\ uniform\\:\\ 0\\.058231281718154344\ \(0\)\
\-\ punctate\\:\\ 0\\.058025772866996624\ \(0\)\
\-\ sustained\\:\\ 0\\.05687605615764277\ \(0\)\
\-\ presumed\\:\\ 0\\.05687605615764277\ \(0\)\
\-\ produced\\:\\ 0\\.056696944529117395\ \(0\)\
\-\ essentially\\:\\ 0\\.05634828925660858\ \(0\)\
\-\ illness\\:\\ 0\\.05601165900548808\ \(0\)\
\-\ various\\:\\ 0\\.05568625187704976\ \(0\)\
\-\ to\\:\\ 0\\.055681625716713576\ \(0\)\
\-\ worsened\\:\\ 0\\.055527527894050854\ \(0\)\
\-\ radiographically\\:\\ 0\\.055527527894050854\ \(0\)\
\-\ reflex\\:\\ 0\\.05506627784241914\ \(0\)\
\-\ findings\\:\\ 0\\.05496266323938185\ \(0\)\
\-\ multiple\\:\\ 0\\.05447061797428725\ \(0\)\
\-\ dizziness\\:\\ 0\\.05434288696183398\ \(0\)\
\-\ achilles\\:\\ 0\\.05434288696183398\ \(0\)\
\-\ multifocal\\:\\ 0\\.05406790230224131\ \(0\)\
\-\ glucose\\:\\ 0\\.05380045242486566\ \(0\)\
\-\ exclude\\:\\ 0\\.05380045242486566\ \(0\)\
\-\ lesion\\:\\ 0\\.05339043958267856\ \(0\)\
\-\ late\\:\\ 0\\.0525631897486211\ \(0\)\
\-\ meningitis\\:\\ 0\\.052447669940296635\ \(0\)\
\-\ seen\\:\\ 0\\.052429329036286255\ \(0\)\
\-\ protein\\:\\ 0\\.05167518603144837\ \(0\)\
\-\ images\\:\\ 0\\.05151332272380217\ \(0\)\
\-\ suggests\\:\\ 0\\.05136196204966467\ \(0\)\
\-\ serial\\:\\ 0\\.05125974844683985\ \(0\)\
\-\ for\\:\\ 0\\.05063041806170133\ \(0\)\
\-\ times\\:\\ 0\\.05011003173748598\ \(0\)\
\-\ asymmetric\\:\\ 0\\.05011003173748598\ \(0\)\
\-\ observed\\:\\ 0\\.0495822648364518\ \(0\)\
\-\ unlikely\\:\\ 0\\.04932871006445094\ \(0\)\
\-\ though\\:\\ 0\\.04837563070707331\ \(0\)\
\-\ hemorrhagic\\:\\ 0\\.048300253422262365\ \(0\)\
\-\ included\\:\\ 0\\.048151222895747726\ \(0\)\
\-\ symmetric\\:\\ 0\\.04771731546669304\ \(0\)\
\-\ even\\:\\ 0\\.04683854230328379\ \(0\)\
\-\ apparent\\:\\ 0\\.04658333012235163\ \(0\)\
\-\ admission\\:\\ 0\\.04645818340975275\ \(0\)\
\-\ clinically\\:\\ 0\\.04627342123989594\ \(0\)\
\-\ complaints\\:\\ 0\\.045855441978439965\ \(0\)\
\-\ neurological\\:\\ 0\\.045739234536014445\ \(0\)\
\-\ suggestive\\:\\ 0\\.04534306904034627\ \(0\)\
\-\ four\\:\\ 0\\.04512370453054207\ \(0\)\
\-\ before\\:\\ 0\\.04501584365542927\ \(0\)\
\-\ characteristic\\:\\ 0\\.04501584365542927\ \(0\)\
\-\ lumbar\\:\\ 0\\.044962356892137643\ \(0\)\
\-\ junction\\:\\ 0\\.04459593762950789\ \(0\)\
\-\ neurologic\\:\\ 0\\.04449372402668306\ \(0\)\
\-\ typical\\:\\ 0\\.04303268631047647\ \(0\)\
\-\ subsequent\\:\\ 0\\.042154203036736185\ \(0\)\
\-\ process\\:\\ 0\\.04176212985690284\ \(0\)\
\-\ pattern\\:\\ 0\\.04157184488633335\ \(0\)\
\-\ course\\:\\ 0\\.04112974775138883\ \(0\)\
\-\ hospital\\:\\ 0\\.04112974775138883\ \(0\)\
\-\ antibiotics\\:\\ 0\\.04102228270401184\ \(0\)\
\-\ ago\\:\\ 0\\.04074136231308546\ \(0\)\
\-\ abnormalities\\:\\ 0\\.04033458221008879\ \(0\)\
\-\ early\\:\\ 0\\.04013737732359817\ \(0\)\
\-\ presence\\:\\ 0\\.04000808656089355\ \(0\)\
\-\ cortical\\:\\ 0\\.039976029685193745\ \(0\)\
\-\ later\\:\\ 0\\.0398488446953109\ \(0\)\
\-\ sclerosis\\:\\ 0\\.039661121412166545\ \(0\)\
\-\ 25\\:\\ 0\\.03944657849291606\ \(0\)\
\-\ then\\:\\ 0\\.03941631084113746\ \(0\)\
\-\ obtained\\:\\ 0\\.03938613675257387\ \(0\)\
\-\ new\\:\\ 0\\.03852173960041919\ \(0\)\
\-\ initial\\:\\ 0\\.037353657297919486\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.037280538529980596\ \(0\)\
\-\ finding\\:\\ 0\\.036600604714661006\ \(0\)\
\-\ revealed\\:\\ 0\\.036510430310077044\ \(0\)\
\-\ differential\\:\\ 0\\.03617950675884285\ \(0\)\
\-\ area\\:\\ 0\\.03607164588373005\ \(0\)\
\-\ mr\\:\\ 0\\.03602883305247795\ \(0\)\
\-\ while\\:\\ 0\\.035986207177416324\ \(0\)\
\-\ frontal\\:\\ 0\\.035838465612989596\ \(0\)\
\-\ such\\:\\ 0\\.035817541039323234\ \(0\)\
\-\ some\\:\\ 0\\.035034611640042686\ \(0\)\
\-\ enhancing\\:\\ 0\\.034881489913926665\ \(0\)\
\-\ only\\:\\ 0\\.034786994404646734\ \(0\)\
\-\ demonstrated\\:\\ 0\\.0342206979171046\ \(0\)\
\-\ month\\:\\ 0\\.033872042644595785\ \(0\)\
\-\ infection\\:\\ 0\\.033635188150197136\ \(0\)\
\-\ appearance\\:\\ 0\\.03356855778993201\ \(0\)\
\-\ following\\:\\ 0\\.033403944953344436\ \(0\)\
\-\ weeks\\:\\ 0\\.03337135290344139\ \(0\)\
\-\ focal\\:\\ 0\\.033306493462970224\ \(0\)\
\-\ all\\:\\ 0\\.03314620562695297\ \(0\)\
\-\ two\\:\\ 0\\.03306703804070964\ \(0\)\
\-\ time\\:\\ 0\\.03300416304150246\ \(0\)\
\-\ however\\:\\ 0\\.03295727115047301\ \(0\)\
\-\ been\\:\\ 0\\.03244100070389172\ \(0\)\
\-\ lobe\\:\\ 0\\.03217834871792626\ \(0\)\
\-\ enhancement\\:\\ 0\\.032049626282774274\ \(0\)\
\-\ one\\:\\ 0\\.031880595048234275\ \(0\)\
\-\ signal\\:\\ 0\\.03156457853034872\ \(0\)\
\-\ these\\:\\ 0\\.03144365229160219\ \(0\)\
\-\ over\\:\\ 0\\.030961675186369497\ \(0\)\
\-\ is\\:\\ 0\\.03049782263533206\ \(0\)\
\-\ symptoms\\:\\ 0\\.030466070785198567\ \(0\)\
\-\ increased\\:\\ 0\\.030110212062710452\ \(0\)\
\-\ bilateral\\:\\ 0\\.029925595498203877\ \(0\)\
\-\ man\\:\\ 0\\.029478775624792876\ \(0\)\
\-\ without\\:\\ 0\\.0293701948625248\ \(0\)\
\-\ case\\:\\ 0\\.027974063071172676\ \(0\)\
\-\ demonstrates\\:\\ 0\\.027974063071172676\ \(0\)\
\-\ large\\:\\ 0\\.02789947772355743\ \(0\)\
\-\ treatment\\:\\ 0\\.026524321297398148\ \(0\)\
\-\ also\\:\\ 0\\.026191246730316226\ \(0\)\
\-\ within\\:\\ 0\\.025645441284265807\ \(0\)\
\-\ has\\:\\ 0\\.025433944040555413\ \(0\)\
\-\ which\\:\\ 0\\.025319188157509026\ \(0\)\
\-\ that\\:\\ 0\\.02416392727427555\ \(0\)\
\-\ by\\:\\ 0\\.02364583345870712\ \(0\)\
\-\ disease\\:\\ 0\\.023373352020022505\ \(0\)\
\-\ normal\\:\\ 0\\.02273461305000613\ \(0\)\
\-\ be\\:\\ 0\\.022587987001450538\ \(0\)\
\-\ as\\:\\ 0\\.022369460973809326\ \(0\)\
\-\ from\\:\\ 0\\.02211455483748841\ \(0\)\
\-\ not\\:\\ 0\\.021981954022648468\ \(0\)\
\-\ history\\:\\ 0\\.021273771625863004\ \(0\)\
\-\ was\\:\\ 0\\.0194057503111281\ \(0\)\
\-\ or\\:\\ 0\\.019370798298889748\ \(0\)\
